Annual Meeting Daily - Sunday, April 14, 2024

New treatment targets in Alzheimer’s unlocking new possibilities... We are looking beyond the amyloids.

Learn More

www.cognitotx.com

Meeting-at-a-glance

AAN Vision

To be indispensable to our members

AAN Mission

To enhance member career fullfillment and promote brain health for all

American Academy of Neurology 201 Chicago Avenue Minneapolis, MN 55415 USA

Phone: (800) 879-1960 (Toll Free) or (612) 928-6000 (International)

Fax: (612) 454-2744

Email: memberservices@aan.com

Website: AAN.com

AAN Chief Executive Officer: Mary E. Post, MBA, CAE

Writers: Ryan Knoke, Val Lick

Designers: Andrew Imholte, Jim Hopwood

Photography: Will Evans

Annual Meeting Daily is published by the American Academy of Neurology. The American Academy of Neurology’s registered trademarks and service marks are registered in the United States and various other countries around the world. “American Brain Foundation” is a registered service mark of the American Brain Foundation and is registered in the United States.

Presidential

Sanjay Gupta to Headline Top Researchers at This Morning’s Presidential Plenary Session

Renowned neurosurgeon and overall champion for brain health Sanjay Gupta, MD, will headline an impressive lineup of premier lectures for clinically relevant research at this morning’s Presidential Plenary Session from 9:15 a.m. to 12:00 p.m. in the Bellco Theatre. Gupta, who has covered some of the most important health stories in the US and around the globe, will sit down for an exciting 45-minute Q&A with AAN President Carlayne E. Jackson, MD, FAAN, and AAN President Elect Natalia S. Rost, MD, MPH, FAAN, FAHA. The hugely popular session will be moderated by AAN Science Committee Chair Paul M. George, MD, PhD, MSE, FAAN.

Q&A Hosts:

Lectures:

Carlayne E. Jackson, MD, FAAN

AAN President

Presidential Lecture

The Future of Brain Health for All–A Fireside Chat with Dr. Sanjay Gupta

Sanjay Gupta, MD

George C. Cotzias Lecture

The Glymphatic System

Maiken Nedergaard, MD, DMSc

Natalia S. Rost, MD, MPH, FAAN, FAHA

AAN President Elect

Moderator:

Paul M. George, MD, PhD, MSE, FAAN Science Committee Chair

Sidney Carter Award in Child Neurology

PKAN and the Arc of a Career

Susan J. Hayflick, MD, PhD

Robert Wartenberg Lecture

Live “Fireside Chat” to Follow Presidential Plenary Session

Head over to the Research Hub in Exhibit Hall B-E after the session to engage with and ask questions of plenary presenters during the live, 30-minute “Fireside Chat.” Please note that Dr. Sanjay Gupta will not be present for the Research Hub “Fireside Chat.”

Functional Neurological Disorder: La Lésion Dynamique

Mark Hallett, MD, FAAN

Calling All Associate Professors!

Enjoy a networking reception to meet new contacts and connect with your colleagues. Learn what other associate professors have planned for 2024.

This Associate Professor Networking Event runs from 4:00 p.m. to 5:30 p.m. today at Hyatt Regency Denver Silver AB.

Associate Professor Work Group members, from left, Babar Khokhar, MD, FAAN; Samantha K. Holden, MD, MS, FAAN; S. Elizabeth Zauber, MD, FAAN; Brian D. Berman, MD, MS, FAAN, at the 2023 Annual Meeting event in Boston.

Head to Today’s Poster Hall Opening for Latest Research

The always popular Annual Meeting Poster Hall kicks off today at 8:00 a.m. in Exhibit Hall B-E and will run through Wednesday. Look for all-digital displays showcasing the latest research with 11 author standby opportunities for questions taking place today through Wednesday at 6:30 p.m. Look for topic-related “neighborhood” groupings to help you easily navigate your way to the research of most interest to you.

2,600+ accepted abstracts covering 27 specialties

Celebrate Award Winners from the 'Red Carpet' in the Poster Hall

Be sure to visit the AAN awards display in the Poster Hall (located in Exhibit Hall B-E) to recognize and celebrate award winners from a vibrant red carpet backdrop. Share your own red carpet photos on social media using #AANAM and #AANScience

180+ courses

600+ CME credits

8

7plenary sessions interactive learning hubs

Get in Line for Fun at Tonight’s Annual Meeting Party

Join your friends and colleagues—plus the AAN’s mascot, Sarah Bellum™—tonight for a hootin' and hollerin' good time at Denver’s famous National Western Complex. Get ready to enjoy a variety of delicious food stations and western-themed activities, including dueling pianos, and kicking up your heels and line dancing the night away!

The fun will run from 7:00 p.m. to 10:00 p.m. and your attendee badge is your complimentary entry into the party, so be sure to wear it—along with your wildest western duds. If you wish to bring a companion (21+), you can purchase a guest ticket for $125 at Registration, which closes at 6:00 p.m. tonight.

Free shuttles will be provided from the Colorado Convention Center’s Lobby B (near Welton Street) to the Annual Meeting Party every 10-15 minutes from 6:30 p.m. to 8:00 p.m. Return service will be provided at the conclusion of the event to the Hyatt Regency Denver at Colorado Convention Center/Sheraton Denver Downtown and the Hilton Denver City Center/Westin Denver Downtown. Hotels within the AAN block are within walking distance (less than one mile) of these drop-off points. The final departure will take place no later than 10:30 p.m.

Bring movement and neuromuscular focused care to Winchester, Virginia

• Join a thriving neurology practice in a hospital employed setting

• Collaborate with an expert team of more than 30 specialists in neurology, neurosurgery and interventional spine care

• Live and work in the tranquil Shenandoah Valley – just 60 miles outside Washington D.C. Here’s to loving your work... and loving where you live. Contact Valley Health Physician Recruitment 540-536-8025 physicianrecruitment@valleyhealthlink.com valleyhealthlink.com

9 Daily Reminders

For easy access to meeting links, visit AAN.com/QuickLinks.

Annual Meeting

Party Shuttles

Free shuttles will be provided every 10-15 minutes from the Colorado Convention Center’s Lobby B to the Annual Meeting Party from 6:30 p.m. to 8:00 p.m. Return service will be provided at the end of the event (no later than 10:30 p.m.) to the Hyatt Regency Denver at Colorado Convention Center/Sheraton Denver Downtown and the Hilton Denver City Center/Westin Denver Downtown.

Submit Evaluations for CME

Complete your evaluations to get your CME credits by May 1, 2024 (or March 1, 2025, with Annual Meeting On Demand) by using the AAN Conferences mobile app or by visiting AAN.com/AMCME. Transcripts will be available upon evaluation submission. AAN members can also access their transcript via NeuroTracker™ at AAN.com/NeuroTracker.

The AAN will transition to a new customer relationship management system May 2-14, 2024. CME earned during this period won’t appear immediately in NeuroTracker or the member's AAN transcript. Evaluations can still be completed during this transition. CME credits earned during this period should appear by mid- to late-May.

Access Past Content with AAN Rewind

Conference attendees have access to content on AAN Rewind through May 6, 2024. Visit AAN.com/AMOnline and use your 6-digit ID and password to log in. It may take up to 48 hours after course completion for content to become available on AAN Rewind.

AANTV Studio

Stop by the AANTV Studio in Lobby D to witness live interviews being recorded for broadcast throughout the week.

Tomorrow Starts Late!

Rest up after the Annual Meeting Party and use Monday morning to watch past sessions on AAN Rewind in the online platform, catch up on work, or enjoy some downtime before the rest of the week. The program begins at 9:15 a.m. with the Contemporary Clinical Issues Plenary Session in the Bellco Theatre.

Want More Time to Review Programs?

Add Annual Meeting On Demand to your registration now to save up to 55% and extend your access to session recordings through March 1, 2025. Check the back of your badge to see if you already have Annual Meeting On Demand. If not, head to the Online Learning booth in the Grand Concourse or email aanamsupport@cmrus.com by May 6, 2024, to add it to your registration.

Program Slides Available Online

Slides are available online only at AAN.com/Materials or through the AAN Conferences mobile app. You can access program materials through March 1, 2025. (Please note that availability of materials is at the discretion of the specific speaker. Not all sessions will have materials.)

Learn About Sustainability

Sustainability efforts for the 2024 Annual Meeting include using digital communications, prioritizing environmentally friendly materials, and providing water bottle refilling stations. Remember to recycle this issue of Annual Meeting Daily! To learn more, visit AAN.com/AMFAQ

Attendee Lunch

Attendee lunch is included in your registration fee and served from 11:30 a.m.–1:00 p.m.

in Exhibit Hall B-E, near the posters. Lunches are served in compostable boxes as part of the AAN’s sustainability efforts.

View all conference guidelines at AAN.com/ConfGuidelines.

WITH FIRDAPSE® (amifampridine)

The recommended first-line therapy for patients living with Lambert-Eaton myasthenic syndrome (LEMS)1

Clinically proven to maintain muscle strength and mobility2-4

“I’d been riding horses my whole life. The hardest thing about being diagnosed with LEMS was not being able to ride. When your whole lifestyle is taken away by a chronic illness— you think, ‘Life’s over.’ Now, I take FIRDAPSE.”

Tom, living with LEMS

Scan the code to watch a video animation of how FIRDAPSE helps restore communication between neurons and muscle receptors.

IMPORTANT SAFETY INFORMATION

INDICATIONS AND USAGE:

FIRDAPSE is a potassium channel blocker indicated for the treatment of Lambert-Eaton myasthenic syndrome (LEMS) in adults and pediatric patients 6 years of age and older.

FIRDAPSE® (amifampridine) tablets for oral use

BRIEF SUMMARY OF FULL PRESCRIBING INFORMATION FOR FIRDAPSE

INDICATIONS AND USAGE

FIRDAPSE is a potassium channel blocker indicated for the treatment of Lambert-Eaton myasthenic syndrome (LEMS) in adults and pediatric patients 6 years of age and older.

DOSAGE AND ADMINISTRATION

• Administer orally in divided doses (3 to 4 times daily).

• The recommended starting dosage for adults (any weight) and pediatric patients weighing 45 kg or more is 15 mg to 30 mg daily, in divided doses.

- Dosage can be increased by 5 mg daily every 3 to 4 days.

- The maximum single dose is 20 mg.

- Dosage is not to exceed a maximum of 80 mg daily.

• The recommended starting dosage for pediatric patients weighing less than 45 kg is 5 mg to 15 mg daily, in divided doses.

- Dosage can be increased by 2.5 mg daily every 3 to 4 days.

- The maximum single dose is 10 mg.

- Dosage is not to exceed a maximum of 40 mg daily.

CONTRAINDICATIONS

FIRDAPSE is contraindicated in patients with:

• A history of seizures

• Hypersensitivity to amifampridine phosphate or another aminopyridine

WARNINGS AND PRECAUTIONS

Seizures

FIRDAPSE can cause seizures. Seizures have been observed in patients without a history of seizures taking FIRDAPSE at the recommended doses, at various times after initiation of treatment, at an incidence of approximately 2%. Many of the patients were taking medications or had comorbid medical conditions that may have lowered the seizure threshold. Seizures may be dose-dependent. Consider discontinuation or dose-reduction of FIRDAPSE in patients who have a seizure while on treatment.

Hypersensitivity

In clinical trials, hypersensitivity reactions and anaphylaxis associated with FIRDAPSE administration have not been reported. Anaphylaxis has been reported in patients taking another aminopyridine; therefore, it may occur with FIRDAPSE. If anaphylaxis occurs, administration of FIRDAPSE should be discontinued and appropriate therapy initiated.

ADVERSE REACTIONS

The following serious adverse reactions are described elsewhere in the labeling:

• Seizures

• Hypersensitivity

Clinical Trials Experience

Adults

Because clinical trials are conducted under widely varying conditions, adverse reaction rates observed in the clinical trials of a drug cannot be directly compared to rates in the clinical trials of another drug and may not re ect the rates observed in practice.

In controlled and uncontrolled trials (Study 1 and 2) in patients with LEMS, 63 patients were treated with FIRDAPSE, including 40 patients treated for more than 6 months, and 39 patients treated for more than 12 months. In an expanded access program, 139 patients with LEMS were treated with FIRDAPSE, including 102 patients treated for more than 6 months, 77 patients treated for more than 12 months, and 53 patients treated for more than 18 months. Study 1 was a double-blind, placebo-controlled, randomized discontinuation study in adults with LEMS. Following an initial open-label run-in phase (up to 90 days), patients were randomized to either continue FIRDAPSE treatment or transition to placebo for a 14-day double-blind phase. Following nal assessments, patients were allowed to resume FIRDAPSE treatment for up to 2 years (open-label, long-term safety phase of the study).

with an incidence of 5% or greater occurring in the 42 LEMS patients newly initiated on treatment with FIRDAPSE during the run-in phase of the study.

Table

number 877-867-1874 (toll-free), by contacting the Pregnancy Coordinating Center at rdapsepregnancyregistry@ubc.com or by visiting the study website at www. rdapsepregnancystudy.com.

Risk Summary

There are no data on the developmental risk associated with the use of FIRDAPSE in pregnant women. In animal studies, administration of amifampridine phosphate to rats during pregnancy and lactation resulted in developmental toxicity (increase in stillbirths and pup deaths, reduced pup weight, and delayed sexual development) at doses associated with maternal plasma drug levels lower than therapeutic drug levels (see Animal Data). In the U.S. general population, the estimated background risk of major birth defects and miscarriage in clinically recognized pregnancies is 2-4% and 15-20%, respectively. The background risk of major birth defects and miscarriage for the indicated population is unknown.

Data

Animal Data

Oral administration of amifampridine phosphate (0, 7.5, 22.5, or 75 mg/kg/day) to female rats prior to and during mating and continuing throughout organogenesis produced no adverse effects on embryofetal development.

Plasma amifampridine exposure (AUC) at the highest dose tested is approximately 7 times that in humans at the maximum recommended human dose (MRHD) of 80 mg amifampridine/day. Oral administration of amifampridine phosphate (0, 9, 30, or 57 mg/kg/day) to pregnant rabbits throughout organogenesis produced no adverse effects on embryofetal development. The highest dose tested is approximately 7 times the MRHD (80 mg/day amifampridine) on a body surface area (mg/m2) basis.

*Includes paresthesia, oral paresthesia, oral hypoesthesia

**Includes elevated alanine aminotransferase (ALT), aspartate aminotransferase (AST), lactate dehydrogenase (LDH), and gamma-glutamyl transferase (GGT)

Other Adverse Reactions

In the overall population treated in Study 1 (n=53), including the double-blind phase and the 2-year open-label long-term safety phase, additional adverse reactions occurring in at least 5% of the patients included: dyspnea, urinary tract infection, gastroesophageal re ux, insomnia, peripheral edema, pyrexia, viral infection, blood creatine phosphokinase increase, depression, erythema, hypercholesterolemia, and in uenza. These patients received an average daily dosage of 66 mg of FIRDAPSE.

Pediatrics

Safety of FIRDAPSE was evaluated in pediatric patients in an expanded access program, where 21 pediatric patients received FIRDAPSE for at least 1 year. Adverse reactions reported in pediatric patients were similar to those seen in adult patients, with the exception of clinically signi cant weight loss in two pediatric patients at doses of 60 mg per day and higher.

DRUG INTERACTIONS

Drugs that Lower Seizure Threshold

The concomitant use of FIRDAPSE and drugs that lower seizure threshold may lead to an increased risk of seizures. The decision to administer FIRDAPSE concomitantly with drugs that lower the seizure threshold should be carefully considered in light of the severity of the associated risks.

Drugs with Cholinergic Effects

Oral administration of amifampridine phosphate (0, 7.5, 22.5, or 75 mg/kg/day) to female rats throughout pregnancy and lactation resulted in an increase in stillbirths and pup deaths, reduced pup weight, and delayed sexual development in female pups at the mid and high doses tested. The no-effect dose (7.5 mg/kg/day amifampridine phosphate) for adverse developmental effects is associated with a plasma amifampridine exposure (AUC) less than that in humans at the MRHD.

Lactation

Risk Summary

There are no data on the presence of FIRDAPSE in human milk, the effects on the breastfed infant, or the effects on milk production. The developmental and health bene ts of breastfeeding should be considered along with the mother’s clinical need for FIRDAPSE and any potential adverse effects on the breastfed infant from FIRDAPSE or from the underlying maternal condition.

In lactating rat, amifampridine was excreted in milk and reached levels similar to those in maternal plasma.

Pediatric Use

Safety and effectiveness of FIRDAPSE for the treatment of LEMS have been established in pediatric patients 6 years of age and older.

Use of FIRDAPSE for this indication is supported by evidence from adequate and well-controlled studies of FIRDAPSE in adults with LEMS, pharmacokinetic data in adult patients, pharmacokinetic modeling and simulation to identify the dosing regimen in pediatric patients, and safety data from pediatric patients aged 6 years and older.

Safety and effectiveness in pediatric patients below the age of 6 years have not been established.

Geriatric Use

During the open-label run-in phase of Study 1, 53 patients received FIRDAPSE for an average of 81 days at an average daily dosage of 50.5 mg/day. The average patient age was 52.1 years and 66% were female. There were 42 patients who had no prior exposure to FIRDAPSE at the initiation of this study. Table 1 shows adverse reactions

amifampridine, and exposure of amifampridine is higher in subjects with renal impairment. Therefore, in patients with renal impairment, FIRDAPSE should be initiated at the lowest recommended initial daily dosage, and patients should be closely monitored for adverse reactions. Consider dosage modi cation or discontinuation of FIRDAPSE for patients with renal impairment as needed based on clinical effect and tolerability. The safety, ef cacy, and pharmacokinetics of amifampridine have not been studied in patients with endstage renal disease (CLcr <15 mL/min or patients requiring dialysis). No dosage recommendation for FIRDAPSE can be made for patients with end-stage renal disease.

Hepatic Impairment

In patients with any degree of hepatic impairment, FIRDAPSE should be initiated at the lowest recommended initial daily dosage, and patients should be monitored for adverse reactions. Consider dosage modi cation or discontinuation of FIRDAPSE for patients with hepatic impairment as needed based on clinical effect and tolerability.

NAT2 Poor Metabolizers

Exposure of FIRDAPSE is increased in patients who are N-acetyltransferase 2 (NAT2) poor metabolizers. Therefore, initiate FIRDAPSE in patients who are known NAT2 poor metabolizers at the lowest recommended initial daily dosage and monitor for adverse reactions. Consider dosage modi cation of FIRDAPSE for patients who are known NAT2 poor metabolizers as needed based on clinical effect and tolerability.

PATIENT COUNSELING INFORMATION

Advise the patient and/or caregiver to read the FDA-approved patient labeling (Medication Guide).

Risk of Seizures

Inform patients that FIRDAPSE can cause seizures, and to notify their healthcare provider if they experience a seizure.

Hypersensitivity

Instruct patients to inform their healthcare provider if they have signs or symptoms of hypersensitivity, and to seek emergency help if symptoms of anaphylaxis occur.

FIRDAPSE Dosing

Instruct patients to take FIRDAPSE exactly as prescribed. Patients should carefully follow the dose escalation schedule provided by their healthcare provider to safely achieve the therapeutic dosage. Inform patients that the tablets may be divided in half at the score, if needed. Instruct patients not to take a double dose to make up for a missed dose.

If they require a dosage in less than 5 mg increments, have dif culty swallowing tablets, or require feeding tubes, refer patients and/or caregivers to the Instructions for Use on how to prepare a 1 mg/mL suspension. If the patient requires treatment with the 1 mg/mL FIRDAPSE suspension, advise patients and/or caregivers that supplies required to prepare the suspension may be obtained at their local pharmacy.

Drug Interactions

Instruct patients to notify their healthcare provider prior to starting any new medication, including over-the-counter drugs.

Pregnancy

Instruct patients that if they are pregnant or plan to become pregnant while taking FIRDAPSE they should inform their healthcare provider. Advise patients that there is a pregnancy registry that monitors pregnancy outcomes in women exposed to FIRDAPSE during pregnancy and encourage them to enroll if they become pregnant while taking FIRDAPSE

Storage

The concomitant use of FIRDAPSE and drugs with cholinergic effects (e.g., direct or indirect cholinesterase inhibitors) may increase the cholinergic effects of FIRDAPSE and of those drugs and increase the risk of adverse reactions.

USE IN SPECIFIC POPULATIONS

Pregnancy

Pregnancy Exposure Registry

There is a pregnancy exposure registry that monitors pregnancy outcomes in women exposed to FIRDAPSE during pregnancy. Physicians are encouraged to enroll pregnant patients, or pregnant women may register themselves in the registry by calling 855-212-5856 (toll-free), using the Fax

Please see FIRDAPSE Brief Summary above and scan the QR code for full Prescribing Information.

Clinical studies of FIRDAPSE did not include suf cient numbers of subjects aged 65 and over (19 of 63 patients in Studies 1 and 2) to determine whether they respond differently from younger subjects. Other reported clinical experience has not identi ed differences in responses between the elderly and younger patients. In general, dose selection for an elderly patient should be cautious, usually starting at the low end of the dosing range, re ecting the greater frequency of decreased hepatic, renal, or cardiac function, and of concomitant disease or other drug therapy.

Renal Impairment

Renal clearance is an elimination pathway for amifampridine and the inactive metabolite, 3-N-acetyl

References: 1. Yoon CH, Owusu-Guha J, Smith A, Buschur P. Amifampridine for the management of LambertEaton myasthenic syndrome: a new take on an old drug. Ann Pharmacother. 2020;54(1):56-63. 2. Full Prescribing Information for FIRDAPSE (amifampridine). Catalyst Pharma; 2023. 3. Oh SJ, Shcherbakova N, Kostera-Pruszczyk A, et al. LEMS Study Group; Amifampridine phosphate (FIRDAPSE®) is effective and safe in a phase 3 clinical trial in LEMS. Muscle Nerve. 2016;53(5):717-725. 4. Shieh P, Sharma K, Kohrman B, Oh SJ. Amifampridine phosphate (FIRDAPSE) is effective in a confirmatory phase 3 clinical trial in LEMS. J Clin Neuromuscul Dis. 2019;20(3):111-119.

1. Adverse Reactions in ≥5% of LEMS Patients Newly Treated with FIRDAPSE in Study 1

Today’s Hub Highlights

Step outside the traditional classroom and into the world of out-of-the-box learning with eight hub areas. Each hub offers unique educational and networking opportunities and creative programs that leave participants with take-home skills and resources for their patients, practices, and careers.

Here are today’s highlights:

Academic Hub

Mile High 1A

ABPN Continuing Certification in Academic Careers

12:30 p.m.–1:15 p.m.

Led by Jeffrey M. Lyness, MD, president and CEO of the American Board of Psychiatry and Neurology (ABPN), and Amy R. Brooks-Kayal, MD, FAAN, this will be an interactive forum with a panel discussing recent activities at the ABPN as well as continuing certification requirements, with an emphasis on how those requirements may be met by neurologists engaged in academic careers.

Lyness Brooks-Kayal

The AAN Anti-racism Education Program

4:45 p.m.–5:30 p.m.

In 2023, 18 US residency programs participated in a yearlong pilot program with the AAN Antiracism Education Program, a core curriculum designed to help AAN members understand the impact of racism on patients and colleagues and to learn how to incorporate anti-racism into their clinical practice and professional life. Each residency developed its own approach to integrate the curriculum into the educational structure. In this panel discussion led by Nimish A. Mohile, MD, FAAN, residency program directors, faculty, and residents will discuss and share their experiences with the pilot.

HeadTalks Lobby B

Lost in Translation

1:45 p.m.–2:45 p.m.

Volunteers will share stories of when they’ve experienced a language or cultural translation issue. Through a series of live interviews and storytelling led by Joseph I. Sirven, MD, FAAN, and Omar A. Danoun, MD, neurologists will share their experiences, both successful and tragic, when different cultures meet.

A Neurologist’s Ultimate Fashion Experience

4:45 p.m.–5:30 p.m.

Get ready to embrace the power of fashion to boost your confidence, express your personality, and make a lasting impression in your professional and personal life with hosts Rachel Marie E. Salas, MD, MEd, FAAN, Hope O'Brien, MD, FAAN, MBA, and Mark Milstein, MD, FAAN. Volunteer “neuro models”—plus Sarah Bellum™—will showcase fashions for a variety of occasions from a regular day in the clinic to presenting at Grand Rounds.

Hope O'Brien, MD, FAAN, MBA, greeted attendees Saturday at Welcome to the Annual Meeting (HeadTalks).

Mohile

Sirven Danoun

Salas O'Brien Milstein

SUNDAY, APRIL 14

Innovation Hub

Exhibit Hall B-E

From Mario to Mechs: The Way Video Games

Alter Neural Connections

11:45 a.m.–12:15 p.m.

Discover how video games alter brain connections in this engaging talk with Jose H.

Posas, MD, FAAN.

Daily Paint and Wine Sessions

12:00 p.m. and 2:00 p.m.

Don’t miss out! These popular sessions fill up fast!

Leadership University

Mile High 4AB

Inclusive Ethics for Medical Professionals

2:00 p.m.–3:30 p.m.

Join Laraine Kaminsky, an expert speaker and consultant on issues of inclusive leadership and cross-cultural competence, and a panel of AAN leaders, to hear about their personal narratives and the practices they use as inclusive leaders. Learn about the core competencies needed to be an inclusive leader.

Developing a Statement of Impact

4:00 p.m.–5:00 p.m.

Na Tosha N. Gatson, MD, PhD, FAAN, and Hope O'Brien, MD, FAAN, MBA, will cover best branding practices for self-promotion, with the goal of helping professionals identify value-added metrics to their institutions, fields of study, and within their communities. Participants will be empowered to best state their impact, grow opportunities for strong collaborations, exercise their “worth ethic,” identify unique valuable skillsets, and nurture ideas for fueling their career trajectories.

Practice and Policy Hub Lobby F

Navigating the Future of Neurology: Unveiling Natural Language Processing’s Impact and Addressing Interoperability Challenges

1:30 p.m.–2:30 p.m.

Learn about the current state of natural language processing (NLP) technology in neurology and its impact on patient care. Lidia Maria Veras Rocha Moura, MD, PhD, MPH, FAAN, Shawn N. Murphy, MD, and Allan Ding Wu, MD, FAAN, will cover best practices for implementing NLP systems in neurology settings and how to apply NLP tools effectively in clinical practice for enhanced patient outcomes.

New Inpatient and Critical Care Coding Guidelines and Challenges

4:00 p.m.–4:30 p.m.

Korwyn Williams, MD, PhD, FAAN, and Sarah Duffy will use case studies to illustrate how to bill appropriately for inpatient services and how documentation can impact level of billing.

Posas

Kaminsky

Gatson O'Brien

Veras Rocha Moura Murphy Ding Wu

Williams Duffy

Today’s Hub Highlights

Research Hub

Exhibit Hall D Lobby

Advancing Workforce Diversity within Neurology Research

3:00 p.m.–3:30 p.m.

Join Karen Dianne Orjuela, MD, FAAN, in identifying the opportunities to increase workforce diversity to positively impact health care outcomes, patients, and families.

Research Success: Dream Big and Plan Small

3:30 p.m.–4:00 p.m.

Carolina B. Maciel, MD, MSCR, FAAN, and Katharina M. Busl, MD, MS, FAAN, call all dreamers to talk about how to envision research success and the overall steps needed to achieve it!

Trainee Hub

Lobby D

Trainee Hub Office Hours

4:30 p.m.–5:30 p.m. today, Monday, and Wednesday

All trainees are invited to these opportunities to connect with faculty about what to do at the Annual Meeting, advice on career paths, ask for CV reviews, or other topics.

Career Planning as an International Medical Graduate

2:30 p.m.–3:30 p.m.

International medical graduates (IMGs) on a visa comprise a quarter of all neurology residents in the US. The need for their expertise has never been greater. However, IMGs who remain in the US after their training face challenges that can limit their opportunities and scope of practice. Come learn about the path to a successful career in neurology as an IMG, with a focus on academic growth; visa issues; and recruitment and counseling strategies for IMG neurologists.

Wellness Hub

Exhibit Hall D Lobby

Magic & Medicine

12:30 p.m.–1:00 p.m.

Your understanding of the world, physics, and the brain will be shaken delightfully as you are guided through a conversation of magic and neurology. You might even discover a secret or two.

Navigating Wellness and Chronic Illness

1:30 p.m.–2:00 p.m.

Eric J. Seachrist, MD, and Indu Subramanian, MD, will lead this discussion on how to maintain wellness in the face of chronic illness.

Medical student Alan Chien amazed attendees at the 2023 Magic & Medicine talk in Boston.

Rodolfo Savica, MD, PhD, FAAN, introduced attendees to Brazilian jiu-jitsu Saturday in the Wellness Hub.

Orjuela

Maciel Busl

Seachrist Subramanian

Treating AD is about more than just removing plaque.

Get the whole story at Eisai Booth 1325.

Calling All Brain Enthusiasts: Charcot’d Breakers Puzzle Series Starts Today!

Dive into the intricate world of neuroscience with Charcot’d Breakers, a captivating puzzle series located throughout the Colorado Convention Center! Just look for the “Charcot’d Breakers” signs to experience a unique blend of brain-teasing challenges, each carefully crafted to stimulate cognitive prowess and test the depths of neurologic knowledge. Complete 10 puzzles (order irrelevant) to receive 10 clues to help solve the final puzzle located at Meeting Information near the Big Blue Bear to earn your prize.

Successfully crack the codes, and you’ll join the esteemed group of Charcot’d Breakers!

AAN Leaders Share 2023 Successes, Look to the Future at Annual Business Meeting

AAN leaders met Saturday to share reports on 2023 activities and finances at the organization’s annual Business Meeting, which was attended by more than 130 Annual Meeting attendees. President Carlayne E. Jackson, MD, FAAN, opened the meeting with a presentation on the AAN’s new strategic plan and record membership; Treasurer Charles C. Flippen II, MD, FAAN, discussed the AAN’s strong financial position; and CEO Mary E. Post, MBA, CAE, shared the AAN’s 2024-2025 priorities.

JOIN THE CONVERSATION #AANAM

Dr. Ava Easton @encephalitisava

Delighted to be at #AANAM #Denver #Colorado @AANmember with @CalumGoodwin_ES representing @encephalitis #encephalitis

Ahmed Negida @ahmed.negia

Attending the American Academy of Neurology Annual Meeting 2024 in Denver, Colorado #AAN #AANAM

Christy Soares (so-ARE-ez), MD @ChristySoaresMD

It’s #AANAM week here in Denver, CO, aka my Super Bowl!! Starting the week off strong moderating our trainee/ early research coffee connect!

UMiami Neurology @UMiamiNeuro

Excited to arrive at #AANAM #AAN2024 in Denver. See old friends! See what’s new! Share expertise!

Maciej M Mrugala, MD, PhD, MPH, FAAN @MrugalaMaciej

Welcome to #AANAM !!!

Students to Explore Career Opportunities, Network at Today’s Symposium

Medical students will have an opportunity to explore career opportunities within neurology at today’s Medical Student Symposium from 12:30 p.m.–5:00 p.m. in Bluebird 1BC. Students will gain an understanding about careers in neurology, the various subspecialty areas in neurology, and be able to network with residents and neurologists.

The event will kick off with a luncheon, where medical students will be seated at a table with a neurologist and resident/fellow. A lively discussion will follow with moderators leading panel discussions on “The Life of a Neurologist” and “The Path to Becoming a Neurologist.”

From 3:15 p.m.–5:00 p.m., students will meet and speak with physicians who represent 20 neurology subspecialties who will share information about their subspecialty, their education and career paths, and how they maintain a work-life balance, before ending the day networking around such subspecialties as:

Behavioral Neurology and Neuropsychiatry

Child Neurology

Epilepsy

General Neurology

Global Neurology

Headache

Industry in Neurology

Movement Disorders

Neuroimmunology and Multiple Sclerosis

Neurocritical Care

Neurodevelopmental Disabilities

Neuroinfectious Disease

Neuromuscular

Neuro-oncology

APPs: Network with Your Colleagues at Today’s Event

Advanced practice providers (APPs) are invited to join the Consortium of Neurology Advanced Practice Providers (CNAPP) this afternoon for a business meeting and networking event. Share ideas and insight with your colleagues from 2:30 p.m. to 3:30 p.m. today at the CNAPP Business Meeting in Hyatt Regency Denver Capitol Ballroom 7. A networking event will follow from 3:30 p.m. to 4:30 p.m. in Capitol Ballroom 5.

Neuro-ophthalmology

Neuropalliative Care

Sleep

Sports Neurology

Vascular/Stroke

Women’s Neurology

Don’t Miss the Second-ever Business Administrator Day at the Annual Meeting!

After a successful debut at the 2023 Annual Meeting, Business Administrator Day is back with another round of learning, dialogue, and networking. This year’s event, themed “Leadership Toolkit: Equipping Today for Tomorrow's Challenges,” starts at 8:00 a.m. Monday in Four Seasons 1. Topics will include building memory disorder centers, breakout sessions to meet the needs of both the private and academic settings, pop culture leadership wisdom, journey to leadership excellence, and leading a multigenerational team. At the end of the program, administrators will have the opportunity to unwind with their peers over wine and appetizers at an exclusive reception.

Benjamin M. Greenberg, MD, FAAN, shared his thoughts on entering the field of neurology with medical students at the 2023 event.

Medical students discussed child neurology with Rana R. Said, MD, FAAN, at the 2023 Annual Meeting in Boston.

AAN Conferences Mobile App Daily Tip

The AAN Conferences mobile app makes it easy to plan your schedule for the meeting. From the main lobby/home screen of the app, go to the Program Search. Select a program, then choose “Add to my schedule.” To find all of your selected programs, look under “My Meeting” and then “My Schedule.” You can also download your schedule to sync with your calendar! Want to share an event or your schedule with someone else? You can email it to them.

New this year! You asked, and we answered! With improved functionality, any programs you save into “My Schedule” in the app will also appear in the online platform and vice versa.

Don’t have the app yet? Download the AAN Conferences mobile app in the App Store or Google Play.

PROVEN PATHOLOGICAL INSIGHTS WITH A SIMPLE SKIN BIOPSY

The only cutaneous test to help diagnose Parkinson’s disease and related disorders

A new diagnostic standard is emerging with the Syn-One Test, offering increased clarity and confidence through reliable detection and visualization of phosphorylated alpha-synuclein in cutaneous nerves.

Learn more about the Syn-One Test cndlifesciences.com

Celebrate These 2024 AAN Service Award Recipients

The AAN recognizes the 2024 AAN service award recipients and their contributions to the art and science of neurology.

AAN PRESIDENT'S AWARD

Ann H. Tilton, MD, FAAN

Louisiana State University, New Orleans, LA

ASSOCIATION OF INDIAN NEUROLOGISTS IN AMERICA

LIFETIME ACHIEVEMENT AWARD

Sponsored by the Association of Indian Neurologists in America Fund of the American Brain Foundation.

Vineeta Singh, MD, FAAN

University of California, San Francisco, San Francisco, CA

BOARD CHAIR AWARD

Sponsored by the American Brain Foundation.

Jim Essey

New York, NY

CHANGEMAKER AWARD

Sponsored by the American Academy of Neurology.

Mill Etienne, MD, MPH, FAAN, FANA, FAES

New York Medical College, Valhalla, NY

GENERAL NEUROLOGY AWARD

Sponsored by the American Academy of Neurology.

Avathvadi V. Srinivasan, MD, FAAN

The Tamilnadu DR MGR Medical University, Chennai, India

KENNETH M. VISTE, JR., MD

PATIENT ADVOCATE OF THE YEAR AWARD

Sponsored by the American Academy of Neurology and endowed by gifts from Dr. Viste’s colleagues, friends, and patients.

Mohammad Wasay, MBBS, FAAN

The Aga Khan University, Karachi, Pakistan

MRIDHA SPIRIT OF NEUROLOGY

HUMANITARIAN AWARD

Sponsored by the American Brain Foundation and funded through the philanthropy of Dr. and Mrs. Mridha.

Alfred Balasa, MD

Baylor College of Medicine, Austin, TX

Michael Rubenstein, MD, FAAN University of Pennsylvania, Philadelphia, PA

NEUROLOGY PRACTICE AWARD

Sponsored by the American Academy of Neurology.

Progressive Neurology

Bergen County, NJ

PUBLIC LEADERSHIP IN NEUROLOGY AWARD

Sponsored by the American Brain Foundation.

Cameron Heyward Pittsburgh, PA

Today’s Society Spotlight Focuses on Hot Topics in Neurocritical Care

QI INNOVATION AWARD

Sponsored by the American Academy of Neurology.

John R. Mytinger, MD

Nationwide Children's Hospital, Columbus, OH

Aneesh B. Singhal, MD, FAAN

Massachusetts General Hospital, Boston, MA

SCIENTIFIC BREAKTHROUGH AWARD

Sponsored by the American Brain Foundation.

Bruce I. Ovbiagele, MD, MSc, FAAN University of California, San Francisco, San Francisco, CA

TED BURNS HUMANISM IN NEUROLOGY AWARD

Sponsored by the American Brain Foundation.

Avindra Nath, MD, MBBS, FAAN NINDS, Bethesda, MD

VOLUNTEER SERVICE AWARD

Sponsored by the American Academy of Neurology.

Mohamed Ibrahim Abdul Aleem, MD, FAAN

ABC Hospital, Trichy, India

The AAN is partnering with the Neurocritical Care Society for today’s Society Spotlight session (formerly Invited Science) from 3:30 p.m. to 5:30 p.m. in room 603. Participants will hear updates on the cutting-edge science of hot topics in neurocritical care from authors giving encore presentations of top abstracts presented at the recent Neurocritical Care Society meeting. Select abstracts will emphasize basic, clinical, and translational science as they evolve toward a more complete understanding of neurocritical care with the overall goal of developing more effective prevention and treatment.

Abstracts and authors include:

3:30 p.m.–3:50 p.m.

Curing Coma Campaign: Scientific Grand Challenge

Claude Hemphill, III, MD, FAAN

3:50 p.m.–4:10 p.m.

The Future of Treating Status Epilepticus

Paul M. Vespa, MD, FAAN

4:10 p.m.–4:30 p.m.

Controversies in Detecting Covert Consciousness in Coma

Jan Claassen, MD, PhD

4:30 p.m.–4:50 p.m.

The Evolving Landscape of Brain Death

Panayiotis N. Varelas, MD, PhD, FAAN

4:50 p.m.–5:10 p.m.

The Near Horizon for Surgery in Intracerebral Hemorrhage

Wendy C. Ziai, MD

5:10 p.m.–5:30 p.m.

Highlights of New Neurocritical Care Guidelines

Sarah Livesay, DNP, RN, NP

“When it was time to start treatment after my diagnosis, my doctor and I chose KESIMPTA.”

Learn how KESIMPTA is part of Caylee’s life at the Novartis booth #1475. —CAYLEE STARTED

Collaborations with Industry Roundtable Improve Annual Meeting Experience

The AAN has long recognized the value of collaborating with industry, and the Industry Roundtable (IRT) is the AAN’s corporate membership program for companies wishing to deepen their relationship with the Academy to share vision, intellect, and financial resources in the mutual pursuit of improved quality of patient care.

While the IRT is active year-round, member companies are particularly engaged at the AAN Annual Meeting, working jointly with the Academy to improve the Annual Meeting experience for all attendees through the valuable support of continuing medical education courses, in-kind donations for workshops, contribution of high-quality research to the scientific program, sponsorship of the Run/Walk for Brain Research, and investment in the future of neurology by supporting the AAN Leadership Development Programs. To learn more about the Industry Roundtable and how your company can deepen its engagement with the AAN, please visit the Industry Lounge in room 401.

Thank you to the following 2024 Industry Roundtable Members.*

$75,000 Members

AbbVie

Acadia Pharmaceuticals

Alexion, AstraZeneca Rare Disease

Amgen

argenx

Eisai

Eli Lilly

Genentech

Lundbeck

Neurocrine Biosciences

Novartis Pharmaceuticals

Novo Nordisk

Pfizer

Reneo Pharmaceuticals

Sanofi

Takeda Pharmaceuticals

UCB, Inc.

Viatris

$50,000 Members

Bristol Myers Squibb

EMD Serono

Supernus Pharmaceuticals

TG Therapeutics

$25,000 Members

Alnylam Pharmaceuticals, Inc.

Amneal Specialty, a division of Amneal Pharmaceuticals LLC

Biogen

Biohaven

Cerevel Therapeutics

Harmony Biosciences

Illumina

Ionis Pharmaceuticals

Ipsen Biopharmaceuticals

Janssen Neuroscience

Jazz Pharmaceuticals

PTC Therapeutics

Xenon Pharmaceuticals

$10,000 Members

Bayer

C2N Diagnostics

Octapharma

RISE Healthcare Group

Roche

Sandoz

*As of March 21, 2024

To enhance member career fulfillment and promote brain health for all.

To be indispensable to our members.

Community Leadership Well-being Diversity, Equity, and Inclusion

Today’s Opening Luncheon Kicks off Four Days of Exhibit Hall Happenings

Make your way to Exhibit Hall B-E today beginning at 11:30 a.m. for the always popular Opening Luncheon that will kick off four days of happenings you won’t want to miss! Open daily from 11:30 a.m.–4:00 p.m. through Wednesday (and through 6:00 p.m. on Monday), the Exhibit Hall promises to be jam packed with countless opportunities to explore, discover, and connect through interactive exhibits, events, and experiences. Learn about the latest advancements in patient care, find products that add efficiencies to your practice, and gather resources that assist patients and caregivers. Building a trip to the Exhibit Hall into your Annual Meeting schedule is the only way to get new information from the diverse, neurology-focused companies that are here to help you and your patients. Use the AAN Conferences mobile app to find more details and locations about specific exhibitors!

Additionally, the Exhibit Hall gives you the opportunity to:

• Have a cup of coffee or specialty hot or iced espresso drink at the Buzz Cafes. Whether you prefer regular or decaf, vegan or half & half, there’s a coffee beverage for you!

• Relax and recharge your devices—and yourself—while connecting to colleagues from the variety of comfortable seating options and locations in the Exhibit Hall Charging Lounges

• Welcome the return of the Innovation Hub with physician talks, paint and wine, and VR!

• Check out the latest research at the Research Hub and Poster Hall

• Learn about pipeline products, new notable companies, and more at the Emerging Neurologic Care Presentation Stage

• Enjoy food and fun at the Monday evening Networking Crawl from 4:00 p.m.–6:00 p.m.

Remember to Complete Your ‘Passport’ to Win Prizes!

Don’t forget to complete your Exhibit Hall Passport for a chance to win prizes, including a grand prize drawing of a 2025 Annual Meeting registration and a three-night stay in an AAN block hotel— compliments of the Academy. Passports are available in the Exhibit Hall.

Opening Luncheon sponsored by AbbVie, Inc.

Explore All Things Brain Health with Targeted Interest Lineup

As neurologists and neuroscience professionals, Annual Meeting attendees uniquely understand how important it is to promote brain health for all. That’s why the 2024 Annual Meeting includes a brain health targeted interest lineup to help attendees explore the countless disciplines of brain health. The AAN is offering content that spans an individual's life course and aligns with the AAN Brain Health Initiative's pillars of science, patient care, public policy, and public education.

Targeted interests, which attendees can browse by visiting AAN.com/events/annual-meeting-targeted-interests or by selecting “By Topic” when looking at the programs in the online platform and mobile app, are suggested lineups of courses, scientific presentations, networking opportunities, hub talks, and more.

Industry Therapeutic Update from UCB:

Harnessing New Potential in Generalized Myasthenia Gravis (gMG)

When individuality meets optionality.

Monday, April 15, 2024

11:45 – 12:45 MT

(Doors will open at 11:15 AM MT)

Colorado Convention Center Room: Bluebird 3A

(Lunch will be provided for session attendees. Seating is limited.)

Neelam Goyal, MD

Stanford University Palo Alto, CA

Nicholas Silvestri, MD, FAAN University at Buffalo Buffalo, NY

Sonia CaraballoCartagena, MD

Advocate Medical Group Downers Grove, IL

This program is NOT accredited for continuing education by any organization. Additionally, Industry Therapeutic Updates program content and the views expressed herein are those of the presenting corporate entity and not of the AAN. These programs are not an official part of the 2024 AAN Annual Meeting education or scientific programs, nor are they endorsed by the AAN.

The AAN cannot affirm claims pertaining to FDA off-label medication, research use of pre-FDA drugs, or other research information that might be discussed. Industry Therapeutic Updates are industry events.

This event is conducted in accordance with the PhRMA Code on Interactions with Health Care Professionals and is limited to health care professionals. Attendance by guests or spouses is not permitted. Federal and state laws restrict and/or require disclosure of items UCB provides to health care professionals, including meals, refreshments, and transportation. UCB is committed to complying with all legal requirements. If you are subject to a restriction based on your practice location, institutional affiliation, or state licensure, UCB kindly asks that you ensure that your attendance at this event complies with those requirements. Attendees from, or licensed in, Minnesota, Vermont, or New Jersey, please identify yourself to a UCB host at the event so that appropriate arrangements can be made to ensure compliance with state requirements. Privacy policy (www.ucb-usa.com/policy).

©2024 UCB, Inc., Smyrna, GA 30080. All rights reserved. US-RZ-2300211

Research Leaders Counsel Trainees on Starting Their Research Careers

The AAN provided trainees looking to launch a career in research with connections, information, and tips for success in Saturday’s Futures in Neurologic Research Boot Camp. Topics included how to frame an impactful question, how to find mentors and sponsors, and rigor in experimental design.

Walter J. Koroshetz, MD, FAAN, director of the National Institute of Neurological Disorders and Stroke, shared the National Institutes of Health perspective and Monica E. Lemmon, MD, covered how to manage your time.

“Trainees also had ample time for meeting in small groups with experts in research,” said H. E. Hinson, MD, MCR, FAAN, chair of the AAN Clinical Research Subcommittee. “The AAN is committed to providing resources to our emerging investigators to strengthen the field of neurology research for tomorrow.”

Neuromodulation: From Bench to Bedside Is Focus of Today’s Neuroscience in the Clinic Session

Today between 1:00 p.m. and 3:00 p.m. in Mile High 1EF join Directors Joshua M. Shulman, MD, PhD, FAAN, and Viviana Gradinaru, PhD; expert faculty Raag Airan, MD, PhD, and Aryn Gittis, PhD; and abstract presenters Amber D. Van Laar, MD, and Ralph Z. Kern, MD, as they discuss targeted, noninvasive study and repair of nervous systems; ultrasonic drug uncaging for noninvasive targeted neuropharmacology; and circuit-inspired strategies to improve treatment for Parkinson’s disease. The session will conclude with a panel discussion and Q&A. Attendees may claim two CME credits.

Amanda C. Peltier, MD, MS, shared insights from her research path in autonomic disorders with trainees at the 2023 Annual Meeting.

Koroshetz

Shulman Gradinaru Airan

Gittis

Van Laar Kern

Lemmon

Job Searching? Take Advantage of These Annual Meeting Opportunities!

Perhaps you’ve come to the Annual Meeting on a mission of sorts. You want to meet up with your colleagues, yes, and of course you want to learn about new developments in neurology. But in the back of your mind, there’s another thought brewing. What if you were to find a great job this week, or at least the lead for one? That’s not unrealistic at all, but it won’t just happen on its own.

As Amy Schoch, Senior Manager, Career Services, says, “There are a lot of people in town for the Annual Meeting and there’s a lot of mutual interest. But candidates have to put in some work to make the connection.” As manager of the AAN’s Neurology Career Center— and a veteran of nearly two dozen AAN Annual Meetings and conferences—Schoch should know. She has been advising neurology candidates and employers on making job matches since 2001. Here are some of her best tips for job-seeking attendees of the Annual Meeting and other AAN-hosted events.

Conference Networking Tips for Job Seekers

1. Use the AAN Career Center early.

By reviewing active job postings on Careers.AAN.com, for example, a potential candidate can identify employers of interest and then arrange to meet up with someone from that organization during the event, says Schoch. Whether that contact is a hiring manager, a recruiter, or a fellow physician who currently works there, he or she could help the candidate make inroads while also providing information about the institution. To make the connection, Schoch suggests simply sending an email to the contact in the posting asking if they want to set up a meeting during the conference.

Does this work? Schoch affirms that it does, sharing this anecdote: “I spoke with someone at a previous Annual Meeting and gave him that suggestion. The next year, he came back to the Career Center booth to say that he had followed the advice and had already had an interview at that year’s Annual Meeting. That tip helped him make the connection that landed him the interview.”

Schoch also advises a careful reading of the postings to reveal upcoming openings. “When a recruitment ad makes note of a new center or building,” she says, “you can anticipate that the institution is growing. Even if you’re not ready to start interviewing, arranging to talk with someone from that employer at the conference can give you a leg up on future opportunities.”

2. Visit the main Career Center booth at the Annual Meeting. You’ll find a wealth of materials to support your job search at the Career Center booth in the Grand Concourse. This year, booth visitors can:

• Get the latest Career Compass Job Guide, which contains helpful articles for the job search process and ads for current job openings.

• Create a Job Alert, which sends relevant jobs straight to your inbox based on criteria you choose like subspecialty or desired location. While supplies last, attendees visiting the booth can receive a free t-shirt for creating a Job Alert!

• Check out the digital job boards, which feature rotating current job openings plus QR codes to help you learn more or even apply on the spot.

• Pick up free pens and plenty of articles on topics from interviewing to contract negotiations.

3. Visit the recruiters in the Exhibit Hall.

If you’ve been to the Annual Meeting Exhibit Hall before, then you know that it can be a very active place. With more than a hundred exhibitors from pharmaceutical companies, software vendors, equipment suppliers, and other organizations, let’s just say it’s easy to be distracted while you’re there. Nevertheless, Schoch wants you to know there are 40+ recruiters and other representatives in the Career Fair Neighborhood who are there to talk turkey on careers at a variety of organizations.

It’s an excellent opportunity to pick up cards and literature that you can use to pursue a contact later, or to learn about current and future openings right there at the booth. You can even drop off your CV or complete a contact form if you’d like someone to reach out to you after the conference. All in all, it’s a very efficient way to connect with multiple organizations.

4. Back by Popular Demand:

Java, Juice and Jobs! Sponsored by the Career Center, this event returns for a second year on Tuesday from 7:00 a.m. to 9:00 a.m. in Bluebird Ballroom 1C. Java, Juice & Jobs is ideal for attendees exploring a new career opportunity, whether they are already in practice or seeking their first job. The event is free to Annual Meeting attendees and features 30+ employer booths, interactive stations, career advice, giveaways, and a complimentary breakfast!

Tips for AAN Junior Members

For residents and fellows still in training, Schoch has this additional advice: Don’t think that your job search days are too far in the future to merit attention now. “It’s never too early to look,” she says. “While you’re completing training is the ideal time to connect with employers—that’s how you’ll know if you’re gaining the skills you’ll need in the workplace.” By the same token, Junior members who network at the conference with doctors on staff at their target employers can gain insight into which procedures or patient experiences they should take extra care to learn while completing their training.

Networking Is for Everyone

Physicians who network know that the real gift of the Annual Meeting and other professional conferences is the opportunity to rub shoulders with colleagues and potential employers. Although it may seem as if jobs for neurologists are already plentiful, it’s networking that makes the difference when you want to break through the competition for a coveted role. Whether you’re meeting with recruiters and employers or simply talking to other attendees, you’ll find that professional conferences are just the ticket when it comes to job search networking.

Deals await you at the booth for Continuum: Lifelong Learning in Neurology®, the AAN’s premier clinical review and CME journal! Stop by the Continuum® booth in Publications located in the Grand Concourse to get a 15% discount on all subscriptions, even on top of the already-discounted AAN member price. AAN members pay just $339 a year with this deal! Annual Meeting attendees can also get free shipping on back issues.

Subscriptions include six print issues per year, online access to Continuum’s complete archive, exclusive access to the audiobookstyle Continuum® Aloud, and subscriber-only content from the journal's newly reimagined podcast, Continuum® Audio. Another great reason to stop by: show us you follow or subscribe to Continuum Audio wherever you get your podcasts for a giveaway with Continuum’s great artwork— available until the supply runs out!

CES: 24 AMOD Ad—Half Page Horizontal> Daily Placed in Daily 8.25 x 5.25 +0.125 bleed, 4C

■

■

■

■

Real Voices of #AANAM

Evan Chung Fort Worth, Texas

As a medical student, what brings you to the Annual Meeting?

My recent interest in neurology. I’m here to learn more from experts in the field, and also to see where the technology is going— that’s one of my huge interests, integrating technology with medicine. I also just want to network with students, residents, fellows, and attendings, who know a lot more than I do right now.

Do you think meetings like this help encourage medical students to choose neurology?

Oh, absolutely. At least at my home institution, I don’t get as much exposure to the full width of neurology—I’ve gotten a lot of outpatient exposure, but not so much inpatient exposure. I think being at an event like this will really help broaden my horizons and see what it’s like in other areas.

Niharika Reddy, MBBS

Lexington, Kentucky

What brings you to the Annual Meeting?

I’m actually working in neuro-oncology at the University of Kentucky. Since I’m planning on going into neurology, I thought the Annual Meeting would be a really good place to start—to attend talks and meet people in the same field.

Would you recommend the meeting to a peer who’s going into neurology?

I would tell them it’s definitely a good place to start. You can attend talks across all of the branches of neurology, which is a great way to decide if you want to go into the field.

Kamel Elzawahry, MD, FAAN

Panama City, Florida

How many Annual Meetings have you attended?

I’ve been a member since 1977, and I must have attended 90% of the Annual Meetings since then—about 40.

What keeps bringing you back?

Education, education, education. In private practice you cannot catch up except through the Academy, and the knowledge that comes from the Academy. It’s sort of like the father of neurology for the whole world, and I love that.

Get the Inside Scoop on Denver—Straight from the Locals!

Who better than your fellow Denver-based AAN member colleagues to offer up an insider’s take on the must-knows to make your week in the Mile High City even more memorable.

Today’s Tip: Eats + Drinks

“For restaurants, I recommend The Fort (outside of Denver), Rodizio, Union Station (several restaurants and shops are in there), Buckhorn Exchange, Safta, and Uchi.”

–Teri Schreiner, MD, MPH, FAAN

“There are several good restaurants downtown, like Casa Bonita. It was a gimmicky restaurant that South Park/Book of Mormon creators Trey Parker and Matt Stone bought, fixed up, and hired an award-winning chef to improve the food.”

–Russell Bartt, MD, FAAN

“One of my favorite restaurants is Work & Class by Executive Chef Dana Rodriguez. She has other great restaurants such as Super Mega Bien, Cantina Loca, and the famous Casa Bonita. Capitol Hill has great views of the mountains and Union Station is an old train station that has good restaurants and bars, and of course the trains! Denver also has amazing beer gardens and local beer.”

–Karen Dianne Orjuela, MD, FAAN

“If you are looking for sushi, my favorite near the city is Izakaya Den. Uchi is another great Japanese restaurant that is a bit closer. Otherwise, Denver is well known for microbreweries and there are many pubs nearby including Woods Boss Brewing, Prost Brewing Company, and Great Divide to name a few. If you are looking for a bite to eat and an activity to go along with it, check out the indoor mini-golf and bar Holey Moley. If you are looking for dinner with music, then I would recommend the Nocturne Jazz Club. If you’re looking for a unique way to relax after a long day at the conference, check

“Colfax Avenue between Colorado Street and Williams Street is filled with interesting and small locally owned restaurants. Cerebral Brewing is a local brewery that makes an interesting variety of beers.”

–Katie Coerver, MD, PhD, FAAN

HELPING TO PRESERVE WHAT MAKES PEOPLE WHO THEY ARE

Through groundbreaking research, expansive partnerships, and dedication to ensuring equitable access to care, Genentech is committed to creating a tomorrow in which neurological disorders no longer limit human potential.

LEARN MORE ABOUT OUR COMMITMENT TO NEUROSCIENCE

Luke Xie Researcher Neuroscience, Genentech

neuron